publication venue for
- Chimeric Antigen Receptor (CAR) T-cell Therapy: A New Genetically Engineered Method of Immunotherapy for Cancer.. 23:199-210. 2023
- Ligand-mediated Targeted Drug Delivery Approaches against Hepatocellular Carcinoma.. 23:879-888. 2023
- Epithelial-to-Mesenchymal Transition: A Mediator of Sorafenib Resistance in Advanced Hepatocellular Carcinoma.. 17:698-706. 2017